Stock Events

Stock Events

Search...

Adaptimmune Therapeutics (ADAP) Q4 2023 Earnings

6MarConfirmed

Q1 2023

Q2 2023

Q3 2023

Q4 2023

-0.24

-0.16

-0.08

0

Details

Expected EPS

-0.1

Actual EPS

-0.24

Surprise EPS

-0.14

Surprise Percent

+140%

Description

Adaptimmune Therapeutics (ADAP) has reported earnings of -0.24 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.